Markets.com Logo

ADMA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    17.2593$
  • Previous Close
    17.7432$
  • 52 Week Change
    12.17$
  • Day Range
    -0.48$
  • 52 Week High/Low
    13.5$ - 25.67$
  • Dividend Per Share
    --
  • Market cap
    4 248 M$
  • EPS
    0.14
  • Beta
    0.378
  • Volume
    --

About

ADMA Biologics, Inc. (ADMA.US) is a commercial biopharmaceutical company dedicated to plasma-derived biologics. They develop, manufacture, and market specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. The company's primary product is BIVIGAM, an intravenous immunoglobulin (IVIG) used to treat primary humoral immunodeficiency (PIDD). They also produce ASCENIV, another IVIG product, and Nabi-HB, a hepatitis B immune globulin. ADMA Biologics operates multiple FDA-approved plasma collection facilities across the United States, sourcing their own plasma to control costs and ensure product quality. The "US" designation signifies that the stock is traded on a United States-based exchange.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

ADMA Biologics' stock price (ADMA.US) is influenced by several factors: Company Performance: Revenue growth, profitability, and successful product development directly impact investor confidence and stock valuation. Regulatory Approvals: FDA approvals for new products or expanded indications are critical catalysts, driving significant price increases. Plasma Supply: The availability and cost of source plasma, a key ingredient in ADMA's products, significantly affects production costs and profitability. Supply chain disruptions can negatively affect the stock price. Competition: The competitive landscape within the plasma-derived biologics market impacts ADMA's market share and pricing power. Competitor actions and new product launches are important considerations. Clinical Trial Results: Positive clinical trial data for ADMA's investigational products can boost investor optimism and drive up the stock price, while negative results can have the opposite effect. Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector influence ADMA's stock valuation. Economic downturns or sector-specific corrections can negatively affect the price. Financial Health: The company's cash position, debt levels, and ability to raise capital influence investor confidence. A strong balance sheet provides stability and allows for growth initiatives. Manufacturing Capacity: The efficiency and capacity of ADMA's manufacturing facilities affect its ability to meet demand and generate revenue.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--